APLS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
APLS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
All Taxes Paid only applicable to companies reporting Cash Flow from Operations in direct method.
James George Chopas | officer: See Remarks | 950 WINTER STREET, WALTHAM MA 02451 |
David O. Watson | officer: General Counsel | 6400 WESTWIND WAY, SUITE A, CRESTWOOD KY 40014 |
Mark Jeffrey Delong | officer: Senior Vice President | 100 5TH AVENUE, 3RD FLOOR, WALTHAM MA 02451 |
Adam J. Townsend | officer: See Remarks | C/O APELLIS PHARMACEUTICALS, INC., 6400 WESTWIND WAY, SUITE A, CRESTWOOD KY 40014 |
Pascal Deschatelets | officer: Chief Operating Officer | 6400 WESTWIND WAY, SUITE A, CRESTWOOD KY 40014 |
Karen Lewis | officer: Chief People Officer | APELLIS PHARMACEUTICALS, INC., 100 5TH AVENUE, 3RD FLOOR, WALTHAM MA 02451 |
Jeffrey Eisele | officer: See Remarks | APELLIS PHARMACEUTICALS, INC., 100 5TH AVENUE, 3RD FLOOR, WALTHAM MA 02451 |
Nur Nicholson | officer: Chief Technical Officer | APELLIS PHARMACEUTICALS, INC., 100 5TH AVENUE, 3RD FLOOR, WALTHAM MA 02451 |
Timothy Eugene Sullivan | officer: Chief Financial Officer | 800 BOYLSTON ST., SUITE 3310, PRUDENTIAL TOWER C/O AJU IB INVESTMENT, BOSTON MA 02199 |
Cedric Francois | director, 10 percent owner, officer: Chief Executive Officer | 6400 WESTWIND WAY, SUITE A, CRESTWOOD KY 40014 |
Caroline Baumal | officer: Chief Medical Officer | C/O APELLIS PHARMACEUTICALS, INC., 100 5TH AVENUE, 3RD FLOOR, WALTHAM MA 02451 |
A. Sinclair Dunlop | director | C/O APELLIS PHARMACEUTICALS, INC., 6400 WESTWIND WAY, SUITE A, CRESTWOOD KY 40014 |
Lukas Scheibler | officer: See Remarks | C/O APELLIS PHARMACEUTICALS, INC., 6400 WESTWIND WAY, SUITE A, CRESTWOOD KY 40014 |
Alec Machiels | director | 505 PARK AVENUE, 21ST FLOOR, NEW YORK NY 10022 |
Federico Grossi | officer: See Remarks | C/O APELLIS PHARMACEUTICALS, INC., 6400 WESTWIND WAY, SUITE A, CRESTWOOD KY 40014 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.